Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Israel Eco Times.
Pomerantz Law Firm Announces the Filing of a Class Action Against MicroStrategy Incorporated d/b/a Strategy and Certain Officers – MSTR
GlobeNewswire, Inc.
·
July 1, 2025
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) and certain officers. The class action,...
Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers – DDD
GlobeNewswire, Inc.
·
July 1, 2025
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against 3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD) and certain officers. The class action, filed in the United...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Designer Brands Inc. - DBI
GlobeNewswire, Inc.
·
July 1, 2025
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Designer Brands Inc. (“Designer Brands” or the “Company”) (NYSE: DBI). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vestis Corporation of Class Action Lawsuit and Upcoming Deadlines - VSTS
GlobeNewswire, Inc.
·
July 1, 2025
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Vestis Corporation (“Vestis” or the “Company”) (NASDAQ: VSTS). Such investors are advised to contact Danielle Peyton at...
Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis
GlobeNewswire, Inc.
·
June 11, 2025
—Achieves FDA Alignment on CMC and Non-Clinical Toxicology Regulatory Path for Nebokitug in PSC— —Preparations for the Nebokitug PSC Phase 3 Clinical Trial Advance as Discussions with Potential Strategic Partners Continue— TEL AVIV, Israel, June...
Odysight.AI (Nasdaq: ODYS) Added to the Russell Microcap® Index
GlobeNewswire, Inc.
·
July 1, 2025
Omer, Israel, July 01, 2025 (GLOBE NEWSWIRE) -- Odysight.AI Inc. (Nasdaq: ODYS), a pioneering developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), was added to the Russell Microcap® Index, effective after...
Maris-Tech Expands Asia-Pacific Reach with New Distribution Agreement in Singapore
GlobeNewswire, Inc.
·
July 1, 2025
Distribution Agreement with Precision Technologies Strengthens Presence in Key Defense and Security Markets Rehovot, Israel, July 01, 2025 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a global leader...
Wearable Devices to Showcase Mudra Link, Its Established AI-Based Neural Wristband for Smart Glasses, at XR Fair Tokyo 2025
GlobeNewswire, Inc.
·
July 1, 2025
YOKNEAM ILLIT, ISRAEL, July 01, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in artificial intelligence (AI)-powered touchless sensing wearable...
Milestone Pharmaceuticals Announces Proposed Public Offering
GlobeNewswire, Inc.
·
July 11, 2025
MONTREAL, Quebec and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST) today announced that it has commenced an underwritten public offering (the “Offering”) of its common shares,...
Milestone Pharmaceuticals Announces FDA Acceptance of the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray
GlobeNewswire, Inc.
·
July 11, 2025
New PDUFA Action Date of December 13, 2025 $75 Million Royalty Purchase Agreement Payment from RTW Extended Through 2025 MONTREAL and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) (Milestone)...
Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder
GlobeNewswire, Inc.
·
June 30, 2025
Vancouver, Canada, June 30, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived...
Quantum Computing Emerging as a Transformative Technology with Potential Applications in Drone Technology
GlobeNewswire, Inc.
·
July 10, 2025
PALM BEACH, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Quantum computing uses the principles of quantum mechanics to process and manipulate information in ways that differ fundamentally from those used by classical...
Beyond Oil Announces Publication of Expert Medical Opinion by Prof. Ilan Ron, Specialist in Clinical and Radiation Oncology, Regarding the Risks Associated with Exposure to Frying Oils as Contributors to Neoplastic Mutations in Body Tissue
GlobeNewswire, Inc.
·
June 18, 2025
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, June 18, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL), a food-tech innovation company dedicated to reducing health risks associated with fried food while lowering operational costs, minimizing...
Hair Serum Market Poised for Growth, Expected to Hit USD 2.35 Billion by 2032 -Coherent Market Insights
GlobeNewswire, Inc.
·
July 10, 2025
Burlingame, CA, July 10, 2025 (GLOBE NEWSWIRE) -- The Global Hair Serum Market is estimated to be valued at USD 1.35 Bn in 2025 and is expected to reach USD 2.35 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.2% from 2025 to...
ControlMonkey Named a Digital Innovator by Intellyx
GlobeNewswire, Inc.
·
June 10, 2025
NEW YORK and TEL AVIV, Israel, June 10, 2025 (GLOBE NEWSWIRE) -- ControlMonkey, the AI-powered cloud infrastructure automation platform, today announced that it has been named a winner of the Summer 2025 Digital Innovator Award, presented by...
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. as of and for the Three Months Ended March 31, 2025
GlobeNewswire, Inc.
·
May 30, 2025
TEL-AVIV, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and...
Egyptian FM states Egypt is working on Gaza truce
MENAFN
·
June 30, 2025
(MENAFN) Egypt’s foreign minister announced on Sunday evening that the country is actively pursuing a new arrangement for Gaza, centered on a 60-day truce. The proposed plan would involve the release of several Israeli hostages in exchange for the...
Egypt Presses for 60-Day Gaza Ceasefire Deal
MENAFN
·
June 30, 2025
(MENAFN) Egypt is actively working on a fresh proposal aimed at achieving a 60-day ceasefire in Gaza, tied to the release of Israeli hostages and the accelerated delivery of humanitarian aid, the country’s foreign minister announced Sunday...
Film Formers Market worth 2.67 Billion by 2032, at 5.2%, says Coherent Market Insights
GlobeNewswire, Inc.
·
July 9, 2025
Burlingame, CA, July 09, 2025 (GLOBE NEWSWIRE) -- The Global Film Formers Market is estimated to be valued at USD 1.87 Bn in 2025 and is expected to reach USD 2.67 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to...
FM spokesperson claims no arms-grade enrichment in Iran
MENAFN
·
June 30, 2025
(MENAFN) Iran has no intention of pursuing nuclear weapons and has never enriched uranium to weapons-grade levels, Foreign Ministry spokesman Esmail Baghaei told RT on Saturday. He strongly criticized recent US and Israeli airstrikes on Iranian...